A plasma protein signature associated with cognitive function in men without severe cognitive impairment

[1]  J. Schott,et al.  Blood biomarkers for Alzheimer's disease and related disorders , 2022, Acta neurologica Scandinavica.

[2]  L. Williams,et al.  Depression and bone loss as risk factors for cognitive decline: A systematic review and meta-analysis , 2022, Ageing Research Reviews.

[3]  Gary D Bader,et al.  The reactome pathway knowledgebase 2022 , 2021, Nucleic Acids Res..

[4]  L. Williams,et al.  Associations Between Muscle Quality and Cognitive Function in Older Men: Cross-Sectional Data From the Geelong Osteoporosis Study. , 2021, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[5]  L. Williams,et al.  Dynapenia and Low Cognition: A Cross-Sectional Association in Postmenopausal Women , 2021, Journal of clinical medicine.

[6]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[7]  A. Díez-Pérez,et al.  Associations between Bone Material Strength Index, Calcaneal Quantitative Ultrasound, and Bone Mineral Density in Men , 2020, Journal of the Endocrine Society.

[8]  L. Williams,et al.  Skeletal Muscle Density and Cognitive Function: A Cross-Sectional Study in Men , 2020, Calcified Tissue International.

[9]  M. Berk,et al.  Anticonvulsant use and bone health in a population-based study of men and women: cross-sectional data from the Geelong Osteoporosis Study , 2020, BMC Musculoskeletal Disorders.

[10]  L. Williams,et al.  Muscle strength and gait speed rather than lean mass are better indicators for poor cognitive function in older men , 2020, Scientific Reports.

[11]  C. Borchers,et al.  Determination of the concentration range for 267 proteins from 21 lots of commercial human plasma using highly multiplexed multiple reaction monitoring mass spectrometry. , 2020, The Analyst.

[12]  P. Schrotz-King,et al.  Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer. , 2020, European journal of cancer.

[13]  Othman Soufan,et al.  NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis , 2019, Nucleic Acids Res..

[14]  Kathryn Goozee,et al.  A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease , 2019, Science Advances.

[15]  J. Rusted,et al.  Affective problems and decline in cognitive state in older adults: a systematic review and meta-analysis , 2018, Psychological Medicine.

[16]  F. de Paula,et al.  Updated Meta-Analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 Variants in Alzheimer’s Disease , 2018, Journal of Molecular Neuroscience.

[17]  J. Hodges,et al.  The Mini-Mental State Examination: pitfalls and limitations , 2016, Practical Neurology.

[18]  M. Berk,et al.  The prevalence and age of onset of psychiatric disorders in Australian men , 2016, The Australian and New Zealand journal of psychiatry.

[19]  S. Bandinelli,et al.  Bone Mineral Density and Cognitive Decline in Elderly Women: Results from the InCHIANTI Study , 2016, Calcified Tissue International.

[20]  Liana G. Apostolova,et al.  Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy , 2016, Neurobiology of Aging.

[21]  A. Kiss,et al.  Depressive symptoms and cognitive decline: A longitudinal analysis of potentially modifiable risk factors in community dwelling older adults. , 2016, Journal of affective disorders.

[22]  L. Williams,et al.  The Epidemiology of Incident Fracture from Cradle to Senescence , 2015, Calcified Tissue International.

[23]  Magda Tsolaki,et al.  Plasma proteins predict conversion to dementia from prodromal disease , 2014, Alzheimer's & Dementia.

[24]  R. Mayeux,et al.  Review - Part of the Special Issue: Alzheimer's Disease - Amyloid, Tau and Beyond Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers , 2014 .

[25]  H. Kiiveri,et al.  A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study , 2014, Molecular Psychiatry.

[26]  J. Pasco,et al.  Cohort profile: Geelong Osteoporosis Study. , 2012, International journal of epidemiology.

[27]  Murray Grossman,et al.  Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease , 2012, Neurology.

[28]  Walter J Koroshetz,et al.  Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. , 2012, Archives of neurology.

[29]  Justin Bedo,et al.  Blood-based protein biomarkers for diagnosis of Alzheimer disease. , 2012, Archives of neurology.

[30]  S. Lovestone,et al.  Plasma biomarkers for Alzheimer's disease: much needed but tough to find. , 2012, Biomarkers in medicine.

[31]  P. Sachdev,et al.  Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals , 2012, PloS one.

[32]  Regina Berretta,et al.  Multivariate Protein Signatures of Pre-Clinical Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Plasma Proteome Dataset , 2012, PloS one.

[33]  Jan-Gowth Chang,et al.  Proteomic Identification of Lower Apolipoprotein A-I in Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.

[34]  J. Cauley,et al.  Bone Loss Predicts Subsequent Cognitive Decline in Older Women: The Study of Osteoporotic Fractures , 2003, Journal of the American Geriatrics Society.

[35]  T. Yaginuma,et al.  Marked decrease of plasma apolipoprotein AI and AII in Japanese patients with late-onset non-familial Alzheimer's disease. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[36]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[37]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..